Selected among Top 40 teams worldwide for Milestone 1 Award in 7-year challenge to restore age-related decline and extend healthy human lifespan.

AgelessRx, a pioneer in longevity and telehealth solutions, has been selected as a Semi-Finalist in the landmark XPRIZE Healthspan competition. The first-of-its-kind longevity telehealth platform joins a select group of 40 global teams receiving Milestone 1 awarding of the $101 million, seven-year competition to extend healthy human healthspan by at least 10 years in adults aged 50–80, with a goal of 20 years, in one year or less. XPRIZE Healthspan is designed to spark bold scientific breakthroughs in healthy aging with the potential to benefit humanity at scale.

“Our work is grounded in the idea that aging is not a single condition, but a complex, multi-system process that requires integrated, personalized care strategies,” said Stefanie Morgan, Ph.D, Vice President of Research and Applied Sciences. “Our goal is to bring rigorous, science-backed longevity care out of the lab and into people’s lives in a way that’s accessible, safe, and clinically meaningful.”

The global longevity economy is projected to exceed $610 billion by 2025, driving an increased demand for solutions that allow people to live healthier, longer. Age-related diseases account for over 55% of global healthcare spending, showing the need for scalable, evidence-based interventions that target the root causes of aging. AgelessRx’s nomination underscores the potential to bring high-impact, clinically guided longevity care at scale while capturing a rapidly growing global market.

Launched nearly three decades ago, XPRIZE was created to incentivize breakthrough solutions in the most critical arenas of science and technology, from spaceflight and climate change to health and human potential. The Healthspan competition, announced in late 2023, is its most ambitious aging-focused initiative yet.

“At AgelessRx, our mission has always been to give people control over their healthspan through evidence-based, clinically guided solutions,” said Dr. Sajad Zalzala, Chief Medical Officer and Co-Founder of AgelessRx. “The PEARL trial allowed us to pioneer the infrastructure and protocols for real-world, decentralized longevity care — laying the foundation for our XPRIZE Healthspan approach. We're excited to continue advancing care that restores years and vitality, not just adds time.”

As part of this phase of the competition, AgelessRx has launched a pilot clinical study enrolling participants aged 65–80 to evaluate the functional and biological impact of its multifaceted healthspan-extending strategy. Participants will undergo:

• DEXA scans for muscle and fat distribution
• Cognitive testing and immune biomarker panels
• Wearable health tracking, all delivered under the guidance of licensed longevity specialists

This 6-month study will help validate the safety and provide indications of longer-term efficacy of AgelessRx’s unique approach to healthspan extension, and will lay the foundation for future large-scale trials and broader clinical adoption.

By combining clinical precision, digital access, and a mission to democratize science-backed longevity care, AgelessRx is proud to stand at the forefront of the healthspan revolution. As demand grows for proven, preventive solutions, this XPRIZE milestone reinforces AgelessRx’s role in delivering therapies that allow users to proactively take control of their health journeys.

To learn more about AgelessRx’s approach to extending healthspan, or to apply for the upcoming pilot study, visit agelessrx.com.

About AgelessRx

AgelessRx is at the forefront of the longevity revolution, offering clinically validated, cutting-edge solutions and preventive treatments aimed at extending life expectancy and enhancing quality of life. AgelessRx also continues to advance the field of longevity science by conducting ongoing research and clinical trials. Through its online platform, AgelessRx provides easy access to innovative healthcare services, with an emphasis on customer satisfaction, affordability, and the pursuit of a future where extended healthspan is a reality for everyone. Follow AgelessRx on Instagram, X, Facebook, and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250512326237/en/